ITRI attends 2013 BIO International Convention Taiwan’s agribiotechnology rides the boom of biotechnology
BIO International Convention 2013 debuted in Chicago on April 22 for a four-day exhibition. This year Chang San-Cheng, Minister without Portfolio of the Executive Yuan, heads Taiwan delegation to the convention. Integrating resources of the industry, government, academics and research, the delegation jointly showcased Taiwan’s R
D capacity of the biotechnology industry in the "Taiwan Pavilion".
The delegation includes the Department of Health (DOH), Development Center for Biotechnology (DCB), Industrial Technology Research Institute (ITRI), Animal Technology Institute, National Research Program for Biopharmaceuticals (NRPB), Science Park Administration, Taiwan External Trade Development Council (TAITRA), Biotechnology and Pharmaceutical Industries Program Office of the Ministry of Economic Affairs and a number of Taiwan's biotech makers.
ITRI hosted the international case study of Innovation
Solutions for Agricultural Biotechnology in Taiwan in the convention.
Dr. Richard Shau, Vice President of ITRI and General Director of ITRI’s Biomedical Technology and Device Research Laboratories, pointed out that the BIO International Convention traditionally has pharmaceuticals as the protagonist. However, the venture capital firms have become more cautious in medical and pharmaceutical investment since the financial crisis. This has given a new opportunity for agribiotechnology to catch on the boom of biotechnology. Agribiotechnology stole the show for a second time in the convention since 2007. Taiwan boasts strength in agricultural technology, such as successful cultivation of orchids, which has turned Taiwan into a reputed orchid growing country. Taiwan’s diversified varieties of tropical fruits are also highly acclaimed. ITRI, acting as the bridge between Taiwan’s agricultural biotechnology research institutes and the international community, conveyed and displayed the brilliant results of Taiwan’s agribiotechnology.
Dr. Richard Shau pointed out that ITRI boasts a host of R
D achievements in agribiotechnology, such as intelligent greenhouse framework, the development of flora growth under illumination of LED lamps, intelligent automatic control systems, and light induction film technology. All of these accomplishments have caught the attention of the market. Furthermore, ITRI has carried out experiments on genotoxicity, cytotoxicity and other kinds of animal experiments, and successfully verified that the Silkies blood can be used as high-value immunomodulatory health food. These are successful stories of applying technology to assist in agricultural transformation or development. At the convention, speakers are concomitantly invited to share the breakthroughs of Taiwan’s agribiotechnology and success stories, including animal gene modification and pigs’ vaccines, etc. Convention attendees had a glimpse of Taiwan’s development potential and innovation in biotechnology in agriculture. We look forward to cooperating with large foreign firms and investment opportunities.
Moreover, ITRI will facilitate the contact between domestic protein-drug firms and international manufacturers at the Convention. Dr. Richard Shau noted that, compared to small molecule medicine and Chinese herbal medicine, protein drugs have comparatively longer efficacy, thereby attracted more and more global pharmaceutical companies to devote to the research and development in this field, particularly in monoclonal antibody technology, Taiwan already has researched and developed protein drugs with fairly good efficacy for treating systemic lupus erythematosus, multiple sclerosis disease, etc. Through this international convention platform, the industry leaders could evaluate opportunities for collaboration with Taiwan for the Asia-Pacific market.
About ITRI
Industrial Technology Research Institute (ITRI) is one of the world’s leading technology R
D institutions aiming to innovate a better future for society. Founded in 1973, ITRI has played a vital role in transforming Taiwan's economy from labor-intensive industry to a leader in high technology. Over the years, ITRI has accumulated over 17,000 patents, cultivated more than 70 CEOs, and incubated 225 innovative companies, including numerous well-known global semiconductor leaders such as TSMC and UMC.
ITRI focuses on the fields of Information and Communications; Electronics and Optoelectronics; Material, Chemical and Nanotechnology; Medical Device and Biomedical; Mechanical and Systems; and Green Energy and Environment. In recognition of its forward-looking and multi-disciplinary R
D innovation, ITRI has been honored with prestigious international awards, such as the Wall Street Journal's Technology Innovation Awards and R
D 100 Awards since 2008. In addition to its headquarters in Taiwan, ITRI has branch offices in Silicon Valley, Tokyo, Berlin and Moscow in an effort to extend its R
D scope and promote opportunities for international cooperation around the world. For more information please visit http://www.itri.org.tw/eng.
Contact Person

Deputy Division Director of Biomedical Technology and Device Research Laboratories, ITRI
Cecile Chen
+886-988-177-566
HLinChen@itri.org.tw
Office of Marketing Communications, ITRI
Kristie Lee

+886-933-727-370
kristielee@itri.org.tw
1



│　
Home
　│　
Sitemap
　│　
中文版
　│　
IP Policy Statement
　│　
Legal Notice
　│　
195, Sec. 4, Chung Hsing Rd., Chutung, Hsinchu, Taiwan 31040, R.O.C.
Tel: +886-3-582-0100　　Fax: +886-3-582-0045
Copyright © 2013 Industrial Technology Research Institute.
var _gaq = _gaq || [];
_gaq.push(['_setAccount', 'UA-28218498-1']);
_gaq.push(['_trackPageview']);
(function() {
var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
})();
此網站網頁設計程式設計由網繹數位科技製作